Chiralabs provides world-leading specialist consultancy, contract research and analytical services for investigating molecular products in the pharmaceutical, biotechnology and chemical industries. A wide range of spectroscopic, physicochemical and theoretical approaches are undertaken to enhance the discovery, development and manufacture of products ranging from small molecular drugs through to biopharmaceuticals, proteins and DNA. Specialist areas include crystallization, molecular chirality, protein/DNA folding & properties and spectroscopic/physicochemical characterisation (circular dichroism a speciality). Chiralabs invented the internationally award winning CrystalGEM® technology for the efficient screening of pharmaceutical crystallization and has pioneered the spectroscopic fingerprinting of biopharmaceuticals for comparability, biosimilarity and troubleshooting. Core to the rational drug discovery process is the understanding of phenomena at the molecular level by the complementary combination of both experimental and theoretical approaches in unison, a principle Chiralabs promotes.